ASX/AIM Announcement                                                                                              1 August 2025

Wellnex Life Limited (ASX/AIM:WNX)

Change of Address

Wellnex Life Limited ("Wellnex" or the "Company") (ASX:WNX  AIM:WNX) advises that it has changed its registered address and principal business address to the following, effective immediately:

BUILDING 2 SUITE 72 LEVEL 3 574 PLUMMER STREET PORT MELBOURNE VIC 3207

This ASX/AIM announcement has been authorised by the Board of Wellnex Life Limited (ASX/AIM:WNX).

For further information, please contact:

Wellnex Life Limited (ASX:WNX)                                  Reach Markets

George Karafotias or Zack Bozinovski                           T: 1300 805 9419

Joint Chief Executive Officers                                        E: [email protected]

P: +61 3 8399 9419

E: [email protected]

UK Investors

Strand Hanson (Financial & Nominated Advisor)     

James Harris / Richard Johnson / Robert Collins             Tel: +44 (0) 20 7409 3494

Orana Corporate LLP (Joint Broker)                                            [email protected]

Sebastian Wykeham     

S.P. Angel Corporate Finance LLP (Joint Broker)            Tel: +44 (0)20 3470 0470

David Hignell / Vadim Alexandre

About Wellnex Life

Wellnex Life Limited (ASX/AIM:WNX) is a consumer healthcare business with a track record for developing, licensing, and marketing registered products and brands to customers in the growing healthcare market segment. Since listing on ASX in 2021, Wellnex Life has successfully launched a host of brands and products now ranged in major retailers in the healthcare market space, pharmacies and supermarkets. Its distribution arrangements have seen Wellnex Life secure significant licensing arrangements with major pharmaceutical companies in Australia and globally that have given the Company's registered products a distribution channel with a steadily increasing global geographic footprint.

In December 2023, Wellnex Life acquired leading Australian topical pain relief brand Pain Away. Its addition to Wellnex Life's product offering both compliments and accelerates the potential growth of the company's business operations. This transformational acquisition gives added impetus to Wellnex Life's financial growth and scale and reinforces its place as a major and respected participant in the growing healthcare market, both in Australia and overseas.

To learn more, please visit: www.Wellnex Lifelife.com.au/